BioSpace News Archive

OSE Immunotherapeutics SA announced that it has received notice of allowance from the European Patent Office for a patent application related to Tedopi®, a neoepitope therapeutic vaccine, protecting a method for manufacturing a ready-to-use peptide emulsion for its use in the treatment of cancers in HLA-A2 positive patients.

The global pharmaceutical logistics market involves a very complex operational process, which is essential as pharmaceuticals are an integral part of the health care industry.

Patient access to quality health and medical care is of the seminal pillars of the healthcare systems around the world.

The rising focus of cost control and efficient hospital stay worldwide is a prime factor augmenting the growth of the global operating room management market.

CatalYm , today announced an update from the dose escalation part of the ongoing first-in-human trial “GDFather” (GDF-15 Antibody-mediated Effector cell Relocation) investigating its lead product candidate, CTL-002, both in monotherapy and in combination with an immune checkpoint inhibitor, nivolumab.

Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that the company will report its financial results for the third quarter ended September 30, 2021 after the market closes on November 8, 2021.

Supernus Pharmaceuticals, Inc. and Adamas Pharmaceuticals, Inc., announced a definitive agreement for Supernus to acquire Adamas through a tender offer for $8.10 per share in cash, payable at closing plus two non-tradable contingent value rights collectively worth up to $1.00 per share in cash, for a total consideration of $9.10 per share in cash.

Pasithea Therapeutics Corp., a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, announced the initiation of a new chemical entity development program and named Evotec as its NCE research partner.

Amydis Inc. today announced a grant award of $3 million from the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH).

CMR Surgical – a global surgical robotics business – announced plans to open a new large-scale manufacturing facility in Cambridgeshire, UK.